VRTX
Vertex Pharmaceuticals Inc
Price:  
469.22 
USD
Volume:  
831,554.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Vertex WACC - Weighted Average Cost of Capital

The WACC of Vertex Pharmaceuticals Inc (VRTX) is 8.1%.

The Cost of Equity of Vertex Pharmaceuticals Inc (VRTX) is 8.15%.
The Cost of Debt of Vertex Pharmaceuticals Inc (VRTX) is 6.95%.

Range Selected
Cost of equity 7.20% - 9.10% 8.15%
Tax rate 15.10% - 16.30% 15.70%
Cost of debt 4.50% - 9.40% 6.95%
WACC 7.2% - 9.1% 8.1%
WACC

Vertex WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.72 0.75
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.20% 9.10%
Tax rate 15.10% 16.30%
Debt/Equity ratio 0 0
Cost of debt 4.50% 9.40%
After-tax WACC 7.2% 9.1%
Selected WACC 8.1%